TMCnet News

Global $756 Million In-Vitro Fertilization (IVF) Market 2016 by Product, Technology & End Users - Forecasts to 2021 - Research and Markets
[August 05, 2016]

Global $756 Million In-Vitro Fertilization (IVF) Market 2016 by Product, Technology & End Users - Forecasts to 2021 - Research and Markets


Research and Markets has announced the addition of the "In Vitro Fertilization (IVF) Market by Product, Technology & End Users - Forecast to 2021" report to their offering.

The in vitro fertilization market is expected to reach USD 756.7 million by 2021 from USD 468.3 million in 2016, at a CAGR of 10.1%

Factors such as declining fertility rates, growth in the media age of first-time motherhood, growing cases of male infertility, growth in healthcare expenditure, rise in consumption of alcohol and cigarettes, implementation of government initiatives and introduction of new and advanced products are driving the in vitro fertilization market. However, high cost coupled with low success rate, and restrictive regulation and ethical concerns are expected to restrain the growth of this market to a certain extent.

The intra-cytoplasmic sperm injection segment accounted for the largest share of the global in vitro fertilization market, by technology, in 2016. Growing incidence of male infertility is contributing to the large share of this segment. The embryo culture media accounted for the largest share of the global in vitro fertilization market, by reagents, in 2016 and is expected to row at the highest CAGR during the forecast period.



Imaging systems segment accounted for the largest share of the global in vitro fertilization market, by equipment, in 2016. However, sperm separation systems are expected to grow at the highest CAGR during the forecast period. The fertility and surgical centers segment accounted for the largest share of the global in vitro fertilization market, by end user, in 2016.

Asia-Pacific accounted for the largest share of the in vitro fertilization market in 2016, followed by Europe and North America. The large share of the Asia-Pacific in vitro fertilization market can primarily be attributed to the high maternal age in Japan, abolishment of China's one child policy, rising fertility tourism in India and Thailand, growing surrogacy and high prevalence of PCOS in India and growing number of ART procedures in Australia and New Zealand. In addition, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period.


Some of the key players in the global in vitro fertilization market are

- Cook Medical, Inc.

- Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)

- EMD Serono, Inc. (Subsidiary of Merck Kgaa)

- Esco Micro Pte. Limited

- Genea Limited

- IVF Tech Aps

- Irvine Scientific

- The Baker Company, Inc.

- Thermo Fisher Scientific, Inc.

- Vitrolife AB

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 In Vitro Fertilization (IVF) Market, By Product

7 In Vitro Fertilization (IVF) Market, By Technology

8 In Vitro Fertilization Market, By End User

9 In Vitro Fertilization (IVF) Market, By Region

10 Competitive Landscape

11 Company Profiles

For more information visit http://www.researchandmarkets.com/research/wztjwv/in_vitro


[ Back To TMCnet.com's Homepage ]